GO:0006002 fructose 6-phosphate metabolic process: Glycolysis and Hexosamine Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006002 (fructose 6-phosphate metabolic process) describes all chemical reactions and pathways involving fructose 6-phosphate (F6P), a central intermediate in glycolysis, gluconeogenesis, and fructose metabolism.
• F6P sits at a metabolic branch point: it can be phosphorylated to fructose 1,6-bisphosphate for glycolysis, converted to glucosamine 6-phosphate by GFPT1/GFPT2 for the hexosamine biosynthetic pathway (HBP), or interconverted with glucose 6-phosphate by phosphoglucose isomerase.
• The hexosamine biosynthetic pathway, which consumes F6P, is critical for O-GlcNAcylation and has been linked to neuromuscular junction transmission, ER stress, cancer progression, and lysosomal function in Parkinson's disease models [1,2,7,8].
• GFPT1 and GFPT2 are the rate-limiting enzymes that divert F6P into the HBP; their dysregulation is implicated in congenital myasthenic syndromes, hepatocellular carcinoma, and breast cancer epithelial-mesenchymal transition [1,6,7].
• F6P metabolism is regulated by fructose-2,6-bisphosphate, which is synthesized and degraded by PFKFB enzymes, and this regulation controls energy metabolism and storage product synthesis in plants and likely other organisms.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal interrogation of genes such as GFPT1, GFPT2, and PFKFB family members in F6P-dependent processes.
Description
Fructose 6-phosphate (F6P) is a six-carbon sugar phosphate that occupies a pivotal position in central carbon metabolism. The Gene Ontology term GO:0006002, fructose 6-phosphate metabolic process, encompasses the chemical reactions and pathways involving this metabolite, which is an important intermediate in glycolysis, gluconeogenesis, and fructose metabolism. Because F6P lies at the intersection of energy production, carbohydrate interconversion, and biosynthetic branching, its metabolic fate is tightly regulated and of broad interest to researchers in cancer biology, neuroscience, and inherited metabolic disorders [1,2,7,8].
fructose 6-phosphate metabolic process At A Glance
| GO ID | GO:0006002 |
|---|---|
| GO term | fructose 6-phosphate metabolic process |
| Ontology | biological_process |
| Synonym | fructose 6-phosphate metabolism |
| Major function | Metabolism of fructose 6-phosphate, a central intermediate in glycolysis, gluconeogenesis, and fructose metabolism |
| Key enzymes | GFPT1, GFPT2, PFKM, PFKL, PFKP, PFKFB1-4, GPI, FBP1, FBP2 |
| Pathway connections | Glycolysis, gluconeogenesis, hexosamine biosynthetic pathway, pentose phosphate pathway (via glucose 6-phosphate) |
| Disease relevance | Congenital myasthenic syndrome, hepatocellular carcinoma, breast cancer, Parkinson's disease models, ER stress-related myopathies |
| Research methods | CRISPR knockout/knock-in, metabolic flux analysis, RNA-seq, proteomics, O-GlcNAcylation profiling |
What Is GO:0006002?
GO:0006002 is defined as the chemical reactions and pathways involving fructose 6-phosphate, also known as F6P. The D-enantiomer is an important intermediate in glycolysis, gluconeogenesis, and fructose metabolism. In practical terms, this term captures enzymatic steps that produce, consume, or interconvert F6P, including its phosphorylation, isomerization, amination, and dephosphorylation, as well as the regulatory circuits that control flux through these reactions.
Why Is fructose 6-phosphate metabolic process Important in Cell Biology?
F6P is not merely a passive glycolytic intermediate; it is a metabolic hub whose flux determines whether carbons are oxidized for ATP, stored as glycogen or fat, or diverted into the hexosamine biosynthetic pathway for protein glycosylation. This branch point is critical for normal physiology and is dysregulated in diseases ranging from congenital myasthenic syndromes to cancer and neurodegeneration [1,2,7,8]. Understanding GO:0006002 therefore provides mechanistic insight into how cells balance energy production with biosynthetic demands.
• F6P is the direct substrate for GFPT1 and GFPT2, the rate-limiting enzymes of the hexosamine biosynthetic pathway, which produces UDP-GlcNAc for O-GlcNAcylation and glycosylation [1,6,7].
• Loss of GFPT1 in muscle causes ER stress and misfolded protein accumulation, highlighting the importance of F6P flux for proteostasis.
• GFPT1 deficiency in mice impairs neuromuscular junction transmission, which can be rescued by galactose treatment, linking F6P metabolism to synaptic function.
• GFPT2 is upregulated during breast epithelial-mesenchymal transition and responds to oxidative stress, connecting F6P metabolism to cancer cell plasticity.
• GFAT1 (GFPT1) promotes hepatocellular carcinoma progression by enhancing O-GlcNAcylation of VEZF1, demonstrating a direct role in oncogenesis.
• The hexosamine biosynthetic pathway, which consumes F6P, rescues lysosomal dysfunction in Parkinson's disease patient iPSC-derived midbrain neurons.
• Fructose-6-phosphate-2-kinase/fructose-2,6-bisphosphatase (PFKFB) regulates energy metabolism and storage product synthesis in developing rice endosperm, showing conservation of F6P regulation across kingdoms.
• F6P phosphorylation in Bacteroides species indicates that F6P metabolism is also relevant in microbial physiology.
• Human erythrocyte F6P levels show an inverse relationship with short-chain fatty acid levels, suggesting systemic metabolic crosstalk.
What Happens During fructose 6-phosphate metabolic process?
Glycolytic phosphorylation of F6P by phosphofructokinase
In simple terms: F6P is converted to fructose 1,6-bisphosphate, committing the sugar to energy production.
The committed step of glycolysis is the phosphorylation of F6P to fructose 1,6-bisphosphate by phosphofructokinase-1 (PFK-1), which is allosterically regulated by energy charge and fructose-2,6-bisphosphate. This reaction is a key control point for glycolytic flux and is conserved across eukaryotes and prokaryotes [3,4].
Hexosamine biosynthetic pathway diversion
In simple terms: F6P can be converted into a building block for protein glycosylation instead of being burned for energy.
GFPT1 and GFPT2 catalyze the conversion of F6P and glutamine to glucosamine 6-phosphate, the first and rate-limiting step of the hexosamine biosynthetic pathway. This pathway produces UDP-GlcNAc, which is used for O-GlcNAcylation and other glycosylation reactions. GFPT1 deficiency in muscle triggers ER stress, and GFPT2 is upregulated in breast cancer EMT and oxidative stress [2,6,7].
Isomerization between glucose 6-phosphate and F6P
In simple terms: F6P can be reversibly converted to glucose 6-phosphate, linking glycolysis to other glucose-utilizing pathways.
Phosphoglucose isomerase (GPI) catalyzes the reversible isomerization of glucose 6-phosphate and F6P. This reaction connects F6P metabolism to the pentose phosphate pathway, glycogen synthesis, and other glucose 6-phosphate-dependent processes. The equilibrium favors F6P under standard conditions, but flux direction depends on cellular context.
Gluconeogenic and fructose metabolism inputs
In simple terms: F6P can be generated from non-carbohydrate sources or from dietary fructose.
During gluconeogenesis, F6P is produced from fructose 1,6-bisphosphate by fructose-1,6-bisphosphatase (FBP1/FBP2). In fructose metabolism, fructokinase and aldolase B generate intermediates that enter the F6P pool. These inputs ensure that F6P levels are maintained even when glucose is scarce.
Regulation by fructose-2,6-bisphosphate
In simple terms: A regulatory molecule made from F6P controls whether sugar is burned or stored.
PFKFB enzymes (PFKFB1-4) synthesize and degrade fructose-2,6-bisphosphate, which is a potent allosteric activator of PFK-1 and inhibitor of FBP1. This dual regulation allows F6P to be directed toward glycolysis or gluconeogenesis depending on hormonal and metabolic signals. In rice endosperm, PFKFB regulates energy metabolism and storage product synthesis, demonstrating its conserved role.
Key Genes Involved in GO:0006002 fructose 6-phosphate metabolic process
The following genes encode enzymes and regulatory proteins that directly participate in or control fructose 6-phosphate metabolic process (GO:0006002).
| Gene | Major Role | Research Relevance |
|---|---|---|
| GFPT1 | Rate-limiting enzyme converting F6P to glucosamine 6-phosphate in HBP | Congenital myasthenic syndrome, ER stress, neuromuscular junction [1,2] |
| GFPT2 | Rate-limiting enzyme converting F6P to glucosamine 6-phosphate in HBP | Breast cancer EMT, oxidative stress response |
| PFKM | Muscle isoform of phosphofructokinase-1, phosphorylates F6P | Glycolytic regulation, exercise physiology |
| PFKL | Liver isoform of phosphofructokinase-1, phosphorylates F6P | Hepatic glycolysis and gluconeogenesis |
| PFKP | Platelet isoform of phosphofructokinase-1, phosphorylates F6P | Cancer metabolism, platelet function |
| PFKFB1 | Synthesizes/degrads fructose-2,6-bisphosphate | Hormonal regulation of glycolysis/gluconeogenesis |
| PFKFB2 | Synthesizes/degrads fructose-2,6-bisphosphate | Cardiac metabolism |
| PFKFB3 | Synthesizes/degrads fructose-2,6-bisphosphate | Angiogenesis, cancer glycolysis |
| PFKFB4 | Synthesizes/degrads fructose-2,6-bisphosphate | Cancer metabolism, oxidative stress |
| GPI | Isomerizes glucose 6-phosphate and F6P | Glycolysis, pentose phosphate pathway crosstalk |
| FBP1 | Dephosphorylates fructose 1,6-bisphosphate to F6P | Gluconeogenesis, tumor suppression |
| FBP2 | Dephosphorylates fructose 1,6-bisphosphate to F6P | Muscle gluconeogenesis |
| ALDOB | Cleaves fructose 1,6-bisphosphate in fructose metabolism | Hereditary fructose intolerance |
| KHK | Phosphorylates fructose to fructose 1-phosphate | Fructose metabolism, metabolic syndrome |
| OGT | O-GlcNAc transferase, uses UDP-GlcNAc from HBP | O-GlcNAcylation, signaling |
| OGA | O-GlcNAcase, removes O-GlcNAc | O-GlcNAcylation cycling |
| GNPNAT1 | Glucosamine-phosphate N-acetyltransferase in HBP | HBP flux |
| PGM3 | Phosphoglucomutase 3 in HBP | HBP flux, immunodeficiency |
How Is fructose 6-phosphate metabolic process Regulated?
Fructose 6-phosphate metabolism is regulated at multiple levels. Allosteric control of PFK-1 by ATP, AMP, citrate, and fructose-2,6-bisphosphate determines glycolytic flux. PFKFB enzymes, which synthesize and degrade fructose-2,6-bisphosphate, are themselves regulated by phosphorylation in response to insulin and glucagon. In the hexosamine biosynthetic pathway, GFPT1 and GFPT2 are feedback-inhibited by UDP-GlcNAc and regulated by oxidative stress and oncogenic signals [6,7]. Additionally, ER stress pathways can be triggered by loss of GFPT1, indicating that F6P flux is monitored by cellular stress responses.
fructose 6-phosphate metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GFPT1 | Congenital myasthenic syndrome, ER stress | Muscle-specific knockout mouse, patient iPSC-derived myotubes |
| GFPT2 | Breast cancer EMT, oxidative stress | Breast cancer cell lines with GFPT2 knockout or overexpression |
| GFPT1 | Hepatocellular carcinoma | HCC cell lines, xenograft models with GFAT1 knockdown |
| HBP pathway | Parkinson's disease lysosomal dysfunction | Patient iPSC-derived midbrain neurons treated with HBP metabolites |
| PFKFB3 | Cancer glycolysis, angiogenesis | Endothelial cells and tumor models with PFKFB3 inhibition |
Congenital myasthenic syndrome and neuromuscular junction dysfunction
Mutations in GFPT1 cause congenital myasthenic syndrome, a disorder characterized by impaired neuromuscular transmission. In a mouse model of GFPT1 deficiency, galactose treatment rescued neuromuscular junction transmission, suggesting that bypassing the HBP defect can restore synaptic function. Muscle-specific loss of Gfpt1 triggers ER stress, which may contribute to the pathology.
Cancer metabolism and epithelial-mesenchymal transition
GFPT2 is upregulated during breast epithelial-mesenchymal transition and responds to oxidative stress, linking F6P flux to cancer cell plasticity. In hepatocellular carcinoma, GFAT1 (GFPT1) promotes progression by enhancing O-GlcNAcylation of VEZF1, a transcription factor involved in tumorigenesis. These findings suggest that targeting F6P-consuming enzymes could be a therapeutic strategy.
Neurodegeneration and lysosomal function
The hexosamine biosynthetic pathway, which consumes F6P, rescues lysosomal dysfunction in Parkinson's disease patient iPSC-derived midbrain neurons. This indicates that F6P metabolism supports lysosomal integrity and may be relevant to neurodegenerative disease mechanisms.
Metabolic and microbial contexts
F6P phosphorylation in Bacteroides species highlights the importance of F6P metabolism in gut microbial physiology. In humans, erythrocyte F6P levels show an inverse relationship with short-chain fatty acid levels, suggesting systemic metabolic crosstalk. In plants, PFKFB regulates energy metabolism and storage product synthesis in rice endosperm.
From fructose 6-phosphate metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of GFPT1 impair neuromuscular junction transmission? | Muscle-specific GFPT1 knockout mouse |
| Does GFPT1 deficiency trigger ER stress in muscle? | Muscle-specific Gfpt1 knockout mouse |
| Does GFPT2 upregulation promote EMT in breast cancer? | GFPT2 overexpression and knockout in breast epithelial cells |
| Does GFAT1 O-GlcNAcylation of VEZF1 drive HCC progression? | HCC cell lines with GFAT1 knockout and VEZF1 point mutants |
| Can HBP metabolites rescue lysosomal dysfunction in Parkinson's disease? | Patient iPSC-derived midbrain neurons treated with HBP intermediates |
| How does PFKFB regulate storage product synthesis? | Rice endosperm with PFKFB knockout or overexpression |
How to Study the fructose 6-phosphate metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| 13C metabolic flux analysis | Flux of labeled carbons through F6P branches | Quantifying glycolysis vs HBP flux |
| O-GlcNAc Western blot | Global O-GlcNAcylation levels | Assessing HBP activity |
| RNA-seq | Transcriptional changes | Identifying ER stress or EMT signatures |
| Proteomics | Protein abundance and modifications | Detecting O-GlcNAcylated targets |
| Electrophysiology | Neuromuscular junction transmission | Evaluating GFPT1 deficiency rescue |
| Lysosomal function assays | Lysosomal pH, enzyme activity, integrity | Parkinson's disease iPSC neurons |
| CRISPR knockout | Gene function loss | Causal testing of F6P enzymes |
| CRISPR knock-in | Tagged or mutant alleles | Tracking protein localization or function |
Metabolic flux analysis
Isotope tracing with 13C-labeled glucose or fructose can quantify flux through F6P into glycolysis, the HBP, and other branches. This method is essential for understanding how genetic perturbations alter F6P metabolism.
O-GlcNAcylation profiling
Because the HBP consumes F6P to produce UDP-GlcNAc, changes in F6P flux can be monitored by measuring O-GlcNAcylated proteins using Western blot with O-GlcNAc antibodies or mass spectrometry-based glycoproteomics [7,8].
Transcriptomics and proteomics
RNA-seq and proteomics can reveal how knockout or overexpression of F6P-metabolizing enzymes affects gene expression programs, such as ER stress responses or EMT markers [2,6].
Functional assays for neuromuscular and lysosomal phenotypes
Electrophysiology at the neuromuscular junction and lysosomal function assays (e.g., LysoTracker, LAMP1 staining) can assess the physiological consequences of F6P pathway perturbations [1,8].
How CRISPR Can Be Used to Study GO:0006002 fructose 6-phosphate metabolic process
Knockout
CRISPR knockout of GFPT1, GFPT2, PFKM, or PFKFB genes can abolish specific F6P metabolic branches, enabling researchers to determine their contribution to glycolysis, HBP flux, and disease phenotypes. For example, muscle-specific Gfpt1 knockout in mice triggers ER stress.
Point Mutation
Point mutations can be introduced to model patient-derived missense variants in GFPT1 or other F6P enzymes, allowing structure-function analysis and testing of targeted therapies. This is particularly relevant for congenital myasthenic syndrome-associated mutations.
Knock-in
Knock-in of epitope tags (e.g., FLAG, HA) or fluorescent proteins into endogenous loci enables real-time tracking of F6P enzyme localization and dynamics without overexpression artifacts. This can be combined with metabolic flux analysis.
Overexpression
Overexpression of GFPT2 or PFKFB3 can drive HBP flux or glycolysis, respectively, to study their roles in cancer EMT or angiogenesis. Inducible overexpression systems allow temporal control of F6P pathway activation.
How EDITGENE Supports fructose 6-phosphate metabolic process Research
Researchers studying fructose 6-phosphate metabolic process-related genes often need to determine whether a candidate gene is causally involved in a specific metabolic or disease phenotype. CRISPR-based models provide the gold standard for such causal interrogation, and EDITGENE offers a comprehensive suite of services to accelerate this work.
Contact EDITGENE today to design your custom CRISPR model for fructose 6-phosphate metabolic process research.
Frequently Asked Questions About fructose 6-phosphate metabolic process
What is fructose 6-phosphate metabolic process?
It is the set of chemical reactions and pathways involving fructose 6-phosphate (F6P), an intermediate in glycolysis, gluconeogenesis, and fructose metabolism, defined by GO:0006002.
What genes are involved in fructose 6-phosphate metabolic process?
Key genes include GFPT1, GFPT2, PFKM, PFKL, PFKP, PFKFB1-4, GPI, FBP1, and FBP2, which encode enzymes that produce, consume, or regulate F6P.
What is the role of GFPT1 in fructose 6-phosphate metabolism?
GFPT1 converts F6P to glucosamine 6-phosphate, the rate-limiting step of the hexosamine biosynthetic pathway, and its deficiency causes congenital myasthenic syndrome and ER stress [1,2].
How is fructose 6-phosphate metabolic process regulated?
It is regulated by allosteric effectors like fructose-2,6-bisphosphate, by PFKFB enzymes, and by feedback inhibition of GFPT1/GFPT2 by UDP-GlcNAc [3,6,7].
What diseases are associated with fructose 6-phosphate metabolic process?
Diseases include congenital myasthenic syndrome, hepatocellular carcinoma, breast cancer, and Parkinson's disease models, linked to GFPT1, GFPT2, and HBP flux [1,6,7,8].
How can CRISPR be used to study fructose 6-phosphate metabolic process?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of genes like GFPT1 and GFPT2 in metabolic and disease phenotypes.
What is the hexosamine biosynthetic pathway?
It is a branch of F6P metabolism that produces UDP-GlcNAc for protein glycosylation, initiated by GFPT1 and GFPT2 [1,6,7].
Why is fructose 6-phosphate important in cancer?
F6P flux into the HBP supports O-GlcNAcylation of oncogenic factors; GFPT2 is upregulated in breast cancer EMT and GFAT1 promotes hepatocellular carcinoma [6,7].
Can fructose 6-phosphate metabolism be targeted therapeutically?
Preclinical studies suggest that modulating HBP flux or PFKFB activity may rescue disease phenotypes, such as galactose rescue in GFPT1-deficient mice.
What methods are used to study fructose 6-phosphate metabolic process?
Methods include metabolic flux analysis, O-GlcNAcylation profiling, RNA-seq, proteomics, electrophysiology, and CRISPR-based genetic models.
Conclusion
GO:0006002 (fructose 6-phosphate metabolic process) represents a central metabolic node with far-reaching implications for energy homeostasis, glycosylation, and disease. The integration of CRISPR-based models with metabolic and proteomic profiling offers a powerful approach to dissect the roles of GFPT1, GFPT2, PFKFB, and other enzymes in this pathway. EDITGENE provides the tools and expertise to accelerate such research.
References
- 1. Holland SH et al.. 2025. Galactose treatment rescues neuromuscular junction transmission in glutamine-fructose-6-phosphate transaminase 1 (Gfpt1) deficient mice.. Hum Mol Genet 34(21):1765-1779 PMID: 40879313
- 2. Zhang R et al.. 2024. Muscle-specific lack of Gfpt1 triggers ER stress to alleviate misfolded protein accumulation.. Dis Model Mech 17(8) PMID: 38903011
- 3. Chen X et al.. 2023. Fructose-6-phosphate-2-kinase/fructose-2,6-bisphosphatase regulates energy metabolism and synthesis of storage products in developing rice endosperm.. Plant Sci 326:111503 PMID: 36270512
- 4. Roberton AM et al.. 1982. Fructose 6-phosphate phosphorylation in Bacteroides species.. J Bacteriol 150(3):1056-60 PMID: 6122675
- 5. Puri BK et al.. 2018. Inverse relationship between human erythrocyte fructose-6-phosphate and short-chain fatty acid levels.. Med Hypotheses 121:164-166 PMID: 30396473
- 6. Wang Q et al.. 2022. Glutamine-Fructose-6-Phosphate Transaminase 2 (GFPT2) Is Upregulated in Breast Epithelial-Mesenchymal Transition and Responds to Oxidative Stress.. Mol Cell Proteomics 21(2):100185 PMID: 34923141
- 7. Yang JY et al.. 2025. GFAT1 promotes the progression of hepatocellular carcinoma via enhancing the O-GlcNAcylation of VEZF1.. Cell Death Dis 16(1):647 PMID: 40858565
- 8. Wani WY et al.. 2024. The hexosamine biosynthetic pathway rescues lysosomal dysfunction in Parkinson's disease patient iPSC derived midbrain neurons.. Nat Commun 15(1):5206 PMID: 38897986
